Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP834167.RAtTx_BmqhjI2DMtK77fIfnyhv5bLrn3abZeRt4mN_Jb8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP834167.RAtTx_BmqhjI2DMtK77fIfnyhv5bLrn3abZeRt4mN_Jb8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP834167.RAtTx_BmqhjI2DMtK77fIfnyhv5bLrn3abZeRt4mN_Jb8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP834167.RAtTx_BmqhjI2DMtK77fIfnyhv5bLrn3abZeRt4mN_Jb8130_provenance.
- NP834167.RAtTx_BmqhjI2DMtK77fIfnyhv5bLrn3abZeRt4mN_Jb8130_assertion description "[Neither the CYP2D6 10/10 genotype nor the CYP2C19 genotype is likely to have a clinically significant impact on prognosis, endometrial thickness, BMD, or total cholesterol levels in Japanese patients with breast cancer who are treated with adjuvant tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP834167.RAtTx_BmqhjI2DMtK77fIfnyhv5bLrn3abZeRt4mN_Jb8130_provenance.
- NP834167.RAtTx_BmqhjI2DMtK77fIfnyhv5bLrn3abZeRt4mN_Jb8130_assertion evidence source_evidence_literature NP834167.RAtTx_BmqhjI2DMtK77fIfnyhv5bLrn3abZeRt4mN_Jb8130_provenance.
- NP834167.RAtTx_BmqhjI2DMtK77fIfnyhv5bLrn3abZeRt4mN_Jb8130_assertion SIO_000772 19156902 NP834167.RAtTx_BmqhjI2DMtK77fIfnyhv5bLrn3abZeRt4mN_Jb8130_provenance.
- NP834167.RAtTx_BmqhjI2DMtK77fIfnyhv5bLrn3abZeRt4mN_Jb8130_assertion wasDerivedFrom befree-20140225 NP834167.RAtTx_BmqhjI2DMtK77fIfnyhv5bLrn3abZeRt4mN_Jb8130_provenance.
- NP834167.RAtTx_BmqhjI2DMtK77fIfnyhv5bLrn3abZeRt4mN_Jb8130_assertion wasGeneratedBy ECO_0000203 NP834167.RAtTx_BmqhjI2DMtK77fIfnyhv5bLrn3abZeRt4mN_Jb8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP834167.RAtTx_BmqhjI2DMtK77fIfnyhv5bLrn3abZeRt4mN_Jb8130_provenance.